Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Kedudukan dalam Saham #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Harga Saham
$0.95011029
Disegerakkan terakhir: 2023-06-28
Modal Pasaran
$57.72M
Perubahan (1 hari)
8.53%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan ERYTECH Pharma S.A. (ERYP)

Kategori

Sejarah harga saham bagi ERYTECH Pharma S.A. (ERYP)
Harga penutupan tertinggi: $0.90 pada 2023-06-01

Harga penutupan terendah: $14.08 pada 2013-05-01
Sejarah harga saham ERYTECH Pharma S.A. dari 2013 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$549.19 38.17%
US
$1.05K 58.07%
NL
$148.12 464.91%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH